Answers are grounded in this paper and cite their sources.
Previous studies indicated that cantharidin (exo-2,3-dimethy-7-oxabicyclo [2,2,1] heptane-2,3-dicarboxylic anhydride) could inhibit the proliferation of cancer cells via p53 dependent mechanism. It could also inhibit protein phosphatases 1(PP1) and protein phosphatases 2A (PP2A). When cantharidin was treated with cancer cell, it could induce to produce oxidative stress.
No takes yet. Share an insight, caveat, or question.
Chi‐Jung Su (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: